Physician profile
Farshid Sanavi
NPI 1356469043
$740.10
in general payments reported to CMS, 2019-2025
9 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.63 · 2021: $66.22 · 2022: $36.89 · 2023: $310 · 2024: $26.14 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250 · Food and Beverage: $167 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250.00 |
| Food and Beverage | $167.36 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $271.67 | 2022-2025 | |
| Straumann USA LLC | $262.07 | 2019-2023 | |
| Dentsply Sirona INC | $45.61 | 2019-2021 | |
| Biolase, INC. | $42.44 | 2023 | Waterlase Iplus |
| Zimmer Biomet Holdings, INC. | $35.37 | 2021 | |
| Dentsply Ih INC. | $24.94 | 2019 | |
| Biohorizons Implant Systems INC. | $22.85 | 2022 | |
| Geistlich Pharma, North America, INC. | $17.86 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $17.29 | 2023 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farshid Sanavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.